Bhat, Tariq A.
Kalathil, Suresh G.
Leigh, Noel J.
Goniewicz, Maciej L.
Thanavala, Yasmin M.
Funding for this research was provided by:
National Heart, Lung and Blood Institute of the National Institutes of Health (RO1HL142511)
US Food and Drug Administration and National Cancer Institute (U54CA238110)
National Cancer Institute, USA (P30CA016056)
Article History
Received: 20 August 2024
Accepted: 27 September 2024
First Online: 19 October 2024
Declarations
:
: All the animals were maintained in pathogen-free environment in barrier facilities at the Roswell Park Comprehensive Cancer Center in Buffalo, NY, with a light/dark cycle of 12/12 hour. All the animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) and complied with all state, federal, and NIH regulations.
: Not applicable.
: Not applicable.
: MLG received a research grant from Pfizer and served as a member of the Scientific Advisory Board to Johnson & Johnson outside of this work; he has also consulted with the US Food and Drug Administration, World Health Organization, and Campaign for Tobacco-Free Kids on the toxicity of tobacco products and tobacco control policies; MLG is also a Member of the IASLC Tobacco Control and Smoking Cessation Committee; and AACR Tobacco Product and Cancer Subcommittee. Others report no conflict of interest.